CPHI 2025

Meet us at CPHI 2025 booth #9.1D64 and explore our options to intensify and optimize your process.

• Explore your path to higher productivity
  Integrated solutions for intensified or continuous mAb processes
• Discover tailored solutions for complex formulations
  Leading-edge strategies ​to advance your pharmaceutical ​manufacturing
• Choose the fast lane
  Leading technologies to accelerate your manufacturing of viral vector-based therapies
• Find your roadmap for efficient processes
  Advanced strategies for manufacturing stable mRNA drug products

Visit our booth to discover the latest products from our Millipore^® and SAFC^® portfolios, including our Mobius^® ADC 100 L Reactor​, Natrix^® CH chromatography membrane,​ and recently launched Non Animal Origin Squalene. Be sure to take the opportunity to consult with our process development experts.

Learn how to maintain compliance with Emprove^® dossiers, our comprehensive documentation that is designed to facilitate your qualification, risk assessment, and process optimization.

Join us to discuss your outsourcing needs and discover how we can support you with our 35+ years of contract development and manufacturing experience and 75+ years of biosafety testing expertise. As your dedicated CDMO and testing partner, we are committed to providing true partnership every step of the way of your drug development journey, from preclinical to commercial.

Talk to our Millipore^® CTDMO Services experts to discover how we can meet your unique program needs with our proven expertise in Small Molecule APIs & HPAPIs, ADC & Bioconjugation, mRNA & LNP, and Viral Vectors.

Attend Our Talk:

Wednesday, October 29, 2025
3.15 pm – 3.40 pm
Location: Next-Gen Bio Theatre – Hall 4.1
Streamlining Qualification of Custom Products in Biopharmaceutical Manufacturing: Solutions for Single-Use Systems and Cell Culture Media
Presenter: Jessica Shea, Senior Program Manager

The customization of single-use systems and cell culture media (CCM) presents significant opportunities for improving pharmaceutical manufacturing efficiencies, including reduced time, enhanced quality, and optimized resource utilization. However, the qualification of these custom products poses challenges, particularly regarding the systematic acquisition and evaluation of essential information. This presentation will explore effective strategies for leveraging custom documentation to speed up the qualification process of single-use assemblies and CCM. This includes:

• Key Criteria: Discussing the initial qualification criteria for selecting custom products
• Overcoming Obstacles: Evaluating common challenges and practical solutions in the qualification of custom single-use assemblies and CCM,
• Compliance Simplified: focus on quality and regulatory compliance documentation.

Register Now:
CPHI 2025
October 28-30, 2025
Messe Frankfurt, Germany
Booth #9.1D64
https://www.cphi.com/europe/en/home.html